Devika Das, MD, MSHQS, FASCO
@DevikaDasMD
Followers
6K
Following
47K
Media
1K
Statuses
10K
Division Director of Hematology/Oncology, Associate Director - Clinical Affairs at the cancer institute @ummc_cancer @ummcMedicine 🫁 Oncology, QI/Safety Expert
Madison,MS
Joined October 2017
If you live in the Jackson area of Mississippi and want to support and create awareness around early diagnosis and guideline concordant treatment for all patients with lung cancer in our state,do join us at the capitol tomorrow AM! 🙏 Together we are strong! #lcsm @UMMC_Cancer
0
1
6
UMMC physicians Drs. Pierre de Delva & Kelsey Koch (thoracic surgery), Dr. Devika Das (hematology oncology), & Jonathan Hontzas, Director of the ACT Center, joined the Mississippi Lung Cancer Round Table meeting alongside members of American Cancer Society & local oncologists.
0
1
4
It's a fact: #LungCancer screening saves lives! LCRF is partnering with the American Lung Cancer Screening Initiative on the PlusOne campaign, which seeks to educate the public by asking: “Do you have a friend or loved one who is eligible for lung cancer screening?” Learn more at
0
6
9
Having moved across states a few times as a faculty member with a young family, I’ve learned that one of the greatest, yet least discussed, challenges is the loss of a village. Beyond friends, it’s the trusted network of caregivers, doctors, neighbors, and community resources
3
5
111
Blue hair, don’t care! 🤣🥰Love this team I get to work with everyday and together we forge the path forward to end cancer mortality in Mississippi! 💪🏼 @rodrocconi @ClarkHenegan @UMMCMedicine A little cheer on this chilly Halloween day! 🎃👻
0
1
3
The monastery at Guadalupe in Estremadura, founded in 1330 by King Alfonso XI of Castile, was also one of Spain’s oldest schools of medicine, particularly specialized in treating syphilis, for which they used fumigations, sudorifics, and mercury brought from the Almadén mines.
0
1
5
Blue hair, don’t care! 🤣🥰Love this team I get to work with everyday and together we forge the path forward to end cancer mortality in Mississippi! 💪🏼 @rodrocconi @ClarkHenegan @UMMCMedicine A little cheer on this chilly Halloween day! 🎃👻
Touchdown for creativity at the Cancer Center and Research Institute! 🏈🎃 Our team brought the spirit of the season to life with a festive display of painted pumpkins — all decked out in a football theme!
0
0
11
New patient podcast on Oncology Unscripted 🥳 We host @RPatelMDPHD to discuss a super hot topic, radiopharmaceuticals/theranostics! Ravi takes us through RPT basics, patient experience, and future research! Not a ton of patient ed out there on this, please share widely!
2
8
15
This #LungCancerAwarenessMonth, @EGFRResisters @YoungLungCancer @OncogeneCancer share the #StoriesOfLungCancer. @jillfeldman4 opens, reminding us that every story is a tapestry of hope, loss & strength. Join us, together, we push for better research, care & more time for all
0
8
18
Dr. Rod Rocconi, Director of UMMC Cancer Center & Research Institute/gynecologic oncologist, continues to CONNECT with oncologists across MS by building relationships that break down barriers to care. He was also a gentleman & lent a hand the OPR by carrying in lunch!
0
1
6
Survivor University helps Mississippians with cancer build strength, knowledge & connection. 💚 Free program open statewide — details: https://t.co/YF04aV1i25
0
1
1
Which bulb produces more near-infrared (NIR) light? Here we have an IR-SENSE photo comparing different light bulbs being operated at the same power. All appear as "warm white" color to the eye but the difference in the amount of invisible NIR light present is
5
11
55
November 7th is the date! Join us for both of these events during lung cancer awareness month. We are stronger and united in this mission to end lung cancer in Mississippi. #lcsm @PierredeDelva1 @KelseyKochMD
@rodrocconi @UMMC_Cancer @AmericanCancer Cc: @EGFRResisters
0
5
18
In our “Challenging Cases” discussion on metastatic NSCLC mEGFR w/ @lungoncdoc we touch on: ✅ Rx options ✅ AE management ✅ Sequencing Full discussion: ⭐️ https://t.co/XFMkB6kxmY ⭐️ Also on the “Oncology Brothers” podcast #OncTwitter @OncUpdates
1
10
31
Impressive results from MDT-BRIDGE at #ESMO25 from Dr. @MartinReck2. Pts with resectable or borderline had 2 cycles of durvalumab + chemo then reassessed at MDT. If resectable at start, 95% remained resectable. If borderline, 82% were then felt to be resectable. #ESMOAmbassadors
2
39
93
🔥 #ESMO25 🇩🇪 🔥 #LCSM Proffered paper, mets ☑️Beamion LUNG 1: Zongertinib as first-line treatment in patients with advanced HER2-mutant NSCLC ☑️ORR 77%, 6m DoR 80%, 6m PFS 79% 🎙️ @DrSanjayPopat
@OncoAlert @myESMO @Larvol
🆙#ESMO25 PREVIEW🇩🇪 🔥#LCSM Proffered paper, mets ✅Beamion LUNG 1: Zongertinib 🎙️ @DrSanjayPopat
@OncoAlert @myESMO @Larvol
0
12
33
1,000 micro-tests later: the pixels confessed and taught your funnel how to do parkour.
0
0
0
0
3
2
Moving target with how this plays out with the use of Chemo/ Osi upfront but good to see more data in this space. A lot of clinicians have successfully been using this strategy with single agent Osimertinib and oligoprogressions . Congratulations to the study team! #lcsm #ESMO25
Dr. @ZPiotrowskaMD discusses NORTHSTAR #ESMO25 - impressive PFS benefit in #EGFR NSCLC when local consolidation therapy added, but notable heterogeneity. Pt selection important, need uniform definitions, biomarkers (radiomics?). Encouraging results here. #ESMOAmbassadors
0
0
5
OPR OUTREACH: CONNECTING THE DOCS (virtually)! Dr. Clark Henegan, hematology/oncology, shared his expertise with Forrest General Hospital’s tumor board in an educational presentation, “Immunotherapy Today: A Genitourinary Oncology Focus.” The OPR loves CONNECTING specialists!
0
2
6